Correlation Between Precision BioSciences and Xilio Development
Can any of the company-specific risk be diversified away by investing in both Precision BioSciences and Xilio Development at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Precision BioSciences and Xilio Development into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Precision BioSciences and Xilio Development, you can compare the effects of market volatilities on Precision BioSciences and Xilio Development and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Precision BioSciences with a short position of Xilio Development. Check out your portfolio center. Please also check ongoing floating volatility patterns of Precision BioSciences and Xilio Development.
Diversification Opportunities for Precision BioSciences and Xilio Development
-0.37 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Precision and Xilio is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Precision BioSciences and Xilio Development in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Xilio Development and Precision BioSciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Precision BioSciences are associated (or correlated) with Xilio Development. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Xilio Development has no effect on the direction of Precision BioSciences i.e., Precision BioSciences and Xilio Development go up and down completely randomly.
Pair Corralation between Precision BioSciences and Xilio Development
Given the investment horizon of 90 days Precision BioSciences is expected to under-perform the Xilio Development. But the stock apears to be less risky and, when comparing its historical volatility, Precision BioSciences is 1.44 times less risky than Xilio Development. The stock trades about -0.07 of its potential returns per unit of risk. The Xilio Development is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 350.00 in Xilio Development on September 26, 2024 and sell it today you would lose (235.00) from holding Xilio Development or give up 67.14% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Precision BioSciences vs. Xilio Development
Performance |
Timeline |
Precision BioSciences |
Xilio Development |
Precision BioSciences and Xilio Development Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Precision BioSciences and Xilio Development
The main advantage of trading using opposite Precision BioSciences and Xilio Development positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Precision BioSciences position performs unexpectedly, Xilio Development can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Xilio Development will offset losses from the drop in Xilio Development's long position.Precision BioSciences vs. Fate Therapeutics | Precision BioSciences vs. Caribou Biosciences | Precision BioSciences vs. Karyopharm Therapeutics | Precision BioSciences vs. Hookipa Pharma |
Xilio Development vs. Fate Therapeutics | Xilio Development vs. Caribou Biosciences | Xilio Development vs. Karyopharm Therapeutics | Xilio Development vs. Hookipa Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
CEOs Directory Screen CEOs from public companies around the world | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |